Project Details

Description

The primary aim of this evaluation is to provide Welsh Government with timely, robust information on the implementation and indicative outcomes of the introduction of Buvidal across Wales, particularly on the wider service impacts and potential future adaptations required as a result of this new treatment.

The evaluation is multi-faceted and includes: a systematic review of the literature on the effectiveness of long-acting injectable buprenorphine, an online stakeholder survey, interviews with stakeholders, focus groups with patients, documentary analyses, secondary data analyses (using the SAIL databank), and workshops with stakeholders to discuss the theory of change underpinning Buvidal. 
StatusActive
Effective start/end date1/07/2331/07/25